When is a neoplasm not a neoplasm? When it is a desmoid

Journal of Surgical Oncology

Volumn 95, Issue 3, 2007, Pages 190-191

  Zippel, Douglas B ^a,b   Temple, Walley J ^a  

^a TOM BAKER CANCER CENTRE   (Canada)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BENIGN TUMOR; CANCER SURGERY; DESMOID TUMOR; EDITORIAL; HUMAN; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; TUMOR DIAGNOSIS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS, HORMONAL; FIBROMATOSIS, AGGRESSIVE; HUMANS; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; PYRAZOLES; SULFONAMIDES; TAMOXIFEN;

EID: 33847218961     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20637     Document Type: Editorial

References (5)

1. Mendenhall WM, Zlotecki RA, Morris CG, et al.: Aggressive fibromatosis. Am J Clin Oncol 2005;28:211-215.
2. Mack LA, Crowe PJ, Yang JL, et al.: Preoperative chemoradiotherapy (modified Eilber protocol) provides maximum local control and minimal morbidity in patients with soft tissue sarcoma. Ann Surg Oncol 2005;12:646-653.
3. Baliski CR, Temple WJ, Arthur K, et ai.: Desmoid tumors: A novel approach for local control. J Surg Oncol 2002;80:96-99.
4. Rock MG, Pritchard DJ, Reiman HM, et al.: Extra-abdominal desmoid tumors. J Bone Joint Surg Am 1984;66:1369-1374.
5. Gronchi A, Casali PG, Mariani L, et al.: Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: A series of patients surgically treated at a single institution. J Clin Oncol 2003;21:1390-1397.